CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) [Phase 2]
Summary
Phase 2 trial update assessing immunogenicity and safety of MenACWY vaccine in infants at 6 and 12 months.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Vaccines | Conditions: Meningococcal Meningitis | Phase 2 | Status: COMPLETED | Results posted: 2013-11-01